Larin Fe 1.5/30 Kit
Product Images NDC 16714-405

8 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Larin Fe 1.5/30 (NDC 16714-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structures of the active ingredients Norethindrone Acetate and Ethinyl Estradiol as shown in the image for the product Larin Fe 1.5/30 kit by Northstar Rx LLC.*
FDA Label Image

Image Reference (Image 02)

Image Reference (Image 02)
A table showing the lowest expected and typical failure rates during the first year of continuous use of various contraceptive methods, including no contraception, oral contraceptives, diaphragm, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical cap, periodic abstinence, withdrawal, and sterilization. The table lists the percentage of women experiencing unintended pregnancy for each method.*
FDA Label Image

Image Relevant (Image 03)

Image Relevant (Image 03)
A text panel warning about the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking, highlighting higher risk in women over 35 and heavy smokers (15 or more cigarettes per day), advising women using oral contraceptives not to smoke.*
FDA Label Image

Image Logo (Image 04)

Image Logo (Image 04)
A bar chart titled 'TABLE II Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' It shows mortality rates for age groups 15–24, 25–34, 35–44, and 45 and older, categorized by smoking status and oral contraceptive use with distinct bar patterns and colors representing ever-users and controls among smokers and non-smokers.*
FDA Label Image

Guide (Image 05)

Guide (Image 05)
A table showing the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. Methods listed include no fertility control, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence, with death rates categorized by age from 15-19 to 40-44 years.*
FDA Label Image

Image Guide (Image 06)

Image Guide (Image 06)
A warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with risk increasing with age and heavy smoking (15 or more cigarettes per day), particularly marked in women over 35 years of age, advising women who use oral contraceptives not to smoke.*
FDA Label Image

Image Logo (Image 07)

Image Logo (Image 07)
An instructional diagram for the Larin Fe 1.5/30 kit illustrating how to start oral contraceptive pills based on the user's menstrual cycle. It shows a hand placing a day label strip above a pill pack labeled with days of the week and instructs users to begin on Sunday or the first day of their period, taking pills from left to right weekly.*
FDA Label Image

Lable Display Panel (Image 08)

Lable Display Panel (Image 08)
A boxed warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. It highlights that the risk rises with age and heavy smoking (15 or more cigarettes per day) and is notably high in women over 35 years old. It advises women who use oral contraceptives not to smoke.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.